Have Medicare & Amyloidosis? Learn How Medicare Rules Impact Your Amyloidosis Treatment and Out of Pocket Costs
30 minAudio
Send us Fan Mail It’s that time of year for Medicare Open Enrollment - a season that impacts so many of our amyloidosis patients. I’ll be speaking with Ann Kayrish, an expert in this area and someone who worked for decades helping Medicare beneficiaries make better choices for both the State Health Insurance Assistance Programs and the National Council on Aging. Today we discuss the different ways doctors participate with Medicare and how participation rules can directly impact your out of pocket costs. We’ll discuss how and where Medicare covers some of the most common (and expensive) amyloidosis treatments and where people can turn if those costs become too much. Lastly we’ll learn what you can expect Medicare to cover if you find yourself enrolled in a clinical trial. Of note, this is Part 2 of a 2-Part discussion on Medicare, so please see our recent episodes for Part 1. For an overview of amyloidosis, please see episode 2 (for clinicians) or episode 3 (for patients).
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
SPEAKER_01Hi everyone. Welcome to the All Things Amyloid Podcast, where we feature patients, caregivers, and clinicians who discuss amyloidosis, a rare and incurable disease. Amyloidosis occurs when the body builds up abnormal amounts of misfolded amyloid protein, which can lead to serious and life-threatening outcomes. I'm your host, McKenzie, an amyloidosis patient and founder of McKenzie's Mission. Our goal for this podcast is to raise awareness and share firsthand what it's like to live with this disease, to care for those affected by it, and to treat it.
SPEAKER_01We hope this leads to earlier diagnosis and start-of-treatment, which will improve patient lives. It's that time of year for Medicare open enrollment, a season that impacts so many of our amyloidosis patients. I'll be speaking with Anne Kairish, an expert in this area, and someone who has worked for decades helping Medicare beneficiaries make better choices for both the state health insurance assistance programs and the National Council on Aging. Today we discuss different ways doctors participate with Medicare and how participation rules can directly impact your out-of-pocket costs.
SPEAKER_01We'll discuss how and where Medicare covers some of the most common and expensive amyloidosis treatments, and where people can turn if those costs become too much. Lastly, we'll learn what you can expect Medicare to cover if you find yourself enrolled in a clinical trial. Of note, this is part two of a two-part discussion on Medicare, so please see our recent episode for part one. Welcome, Anne.
SPEAKER_01It's so great to have you back for part two of our discussion on Medicare and amyloidosis. And before we hone in on the amyloidosis piece, could you help our audience understand Medicare's key coverage rules that dictate whether or not a particular procedure or treatment would be covered?
SPEAKER_00Well, first, it's very nice to be back with you, Mackenzie. I'm always excited to be here to speak with your audience. Like most insurance, uh, it it remains somewhat confusing for people to understand what is covered or how Medicare makes decisions or coverage rules. And um, many times underlying these cover coverage rules are very basic principles. And one of the principles is where you get coverage matters to Medicare.
SPEAKER_00I know for folks with amyloidosis, it's very important that they see a doctor that has experience in treating amyloidosis because they want them to have the expertise needed to cover and to help with that disease. But similarly, Medicare has rules about the doctors that you see, and they want you to use doctors that they that have Medicare provider numbers. And what that means is that Medicare has vetted them and they have the license and all of that to treat the patients.
SPEAKER_00So a doctor that you are going to see for amyliodosis or anything else, and you want Medicare to get the most, you to get the most out of your Medicare coverage, they would need to have a provider number. So when you're first meeting up with your doctor that's treating you, you want to make sure that they indeed are Medicaid, they're Medicare participating. And that is a question that you can ask them. And that's a fair question because you want to make sure they're going to bill Medicare on your behalf.
SPEAKER_00You want to make sure that they accept Medicare's payment on your behalf. There are doctors that opt out of Medicare, but know that 98% of all doctors do indeed participate with Medicare. And that includes specialists. Now, if you're in traditional Medicare, and we spent a lot of time last time we talked about explaining the two different types of pathways that you can receive Medicare care, and that is going with traditional Medicare, where you buy a Part D drug plan and you normally get a Medicare supplement plan, or you go this second path, which is the Medicare Advantage path.
SPEAKER_00And that is an all-in-one combination. And that's normally, that is normally handled through a particular insurer, and they are responsible for your care. If you are with one of those insurers, then, and that's the Medicare Advantage plan, then you need to make sure that the doctor you see is also participating in their network. And that becomes very important because a doctor must be a network in order to get care or get it covered through a Medicare Advantage plan.
SPEAKER_00Okay. Because that means that particular doctor has actually signed a contract with that Medicare Advantage plan. So that's important to know. Um, how do you know if you have a Medicare Advantage plan? How, you know, just if you're not quite sure, I would recommend looking at the card that you have and whether it says HMO, which is a health maintenance organization, or a PPO, which is a preferred provider organization.
SPEAKER_00These are both ways of knowing whether or not you're in a Medicare Advantage plan. And um so that that kind of that kind of helps too. Okay. And if you ensure that your doctor is in that participating Medicare Advantage plan, you can know that your out-of-pocket costs will be as, you know, as as little as or as small as possible.
SPEAKER_01Yeah. And the last time we spoke, we spent a lot of time talking about different parts of Medicare, as you'd mentioned, things like Part A, Part B, the drug uh in Part D, Medicare Advantage. And today I'm really hoping that we can cover how Medicare covers some of the more costly amyloidosis treatments, um, protocols, drugs. And what can you tell us about how Medicare covers these drugs and what kind of rules are at play here?
SPEAKER_00Exactly. It's one of those, just as place of service is important. One of the other underpinnings of Medicare coverage is is it medically necessary? Any treatment you get, any drugs that you take, um, the un the design is that they have to be treating the condition that you're experiencing. So that is one of the things that becomes paramount with with Medicare and really any other insurance. So what they're really saying is um are the drugs that you're taking, and the drugs, many of these expensive drugs, they want to ensure that they're medically appropriate.
SPEAKER_00And often with drugs, you're talking about labeled indications. And what that means, has the FDA, the Food and Drug Administration, approved drugs for the diagnosis or the disease that you're you're experiencing. So that's that's the that's kind of the rule. The other thing which comes into play with Medicare beneficiaries is where are you getting the drug? For the most part, for amyloidosis treatments, you're really splitting uh your treatments or your drug dispensing between Medicare Part A or Medicare Part B, which is you know medical insurance, whether it's at the doctor's office versus Medicare Part D, which is your prescription drug benefit.
SPEAKER_00So those are the two places where Medicare Part B or Medicare Part D, where most of your services for amyloidosis are um happening. When you go to the doctor's office for let's just say a checkup or some kind of testing or MRI, or you're getting a subcutaneous injection or some kind of IV, that's all under Medicare Part B. And normally drugs that are administered under Medicare Part B require professional supervision.
SPEAKER_00All right. And one of the, you know, and then the common drugs with amyloidosis that require that kind of supervision and are covered by Part V B, as in boy, is embruta. And that's undercover by part B and it's a subcutaneous injection, and it needs to be administered by a healthcare professional. Another drug that comes under Medicare Part B is Darzalex. And that is a shot that is normally given in the doctor's office or in a in a clinic. So you can see that that is the that requires Medicare's uh doctor supervision.
SPEAKER_00That's why it's covered under Medicare Part B. What would you pay if you're you know under Medicare Part B? Again, if you're in a um original Medicare or traditional Medicare, what you would have is that 20% coinsurance. And uh and you would be having to pay that Medicare Part B deductible first. That's that$283 in 2026. And then after that's satisfied, you would have that 20% coinsurance.
SPEAKER_00For folks that have a Medigap plan, that is going to pay that 20% coinsurance. For the 50% of people who have the Medicare Advantage plan, their payment structure is going to be a bit different. It's going to go according to what the plan dictates. They have a set of rules that say for an injection in the office, you're going to pay this much. The cost of the injection is going to be this, you're going to pay a percentage of the cost of the injection. But more importantly, what's going to happen with the Medicare Advantage plan is it is likely that for a drug such as Darzelex or Ambruda, you're also going to need a prior authorization.
SPEAKER_00And what the prior authorization means that the doctor that you're seeing is going to have to provide documentation of medical necessity. So you can see how all this comes together. You're going to have to indicate the doctor's going to have to say, my patient needs this because of this diagnosis, blood work indicates this. And that is the proof in order to get that type of injection. So you can see how it's a little bit different when you're going down the traditional Medicare path.
SPEAKER_00You're typically not getting the prior authorization requirement, as opposed to if you're going to the Medicare Advantage route, where it's often you're going to have a prior authorization requirement for the amyloidosis drugs in the office.
SPEAKER_01And for patients who are on oral medications, how does the cost and the coverage differ if you pick up those medications at the pharmacy? You know, we hear a lot about problems of patients having problems getting approval for amyloidosis drugs. So what's what's going on there?
SPEAKER_00Oh, for sure, for sure. I think this is something we hear all hear a lot about. And it can be really frustrating, especially as you know, you're anxious to start that next treatment. You know, the thing being is um with Medicare Part B, um, that is kind of like universally whether it's where both medic traditional Medicare and Medicare Advantage come together. How they cover the drugs that for amyloidosis that you take at home, it's whether it's in a pill form and you pick them at a pharmacy, all of those drugs are going to require prior authorization.
SPEAKER_00And the reason they're going to require prior authorization is really because they're expensive and they we want to ensure that the drugs are being used appropriately. Okay. Now, this uh let's just use, you know, quite, you know, an example of one of those drugs is it a trubi, a trubi? Is that right? Am I saying that right? I never quite know for sure. Okay. That is going to be covered under your Medicare Part D plan. And that indeed, um, and it's designed to be administered at home. And that will likely need a prior authorization from the drug plan.
SPEAKER_00Similarly, similarly, is your Vindamax. And that is now in 2027 also going to be covered by many Part D drug plans. And um that I know is a change from previous years, but again, it was likely going to be need to be pre-authorized. And what I will say for folks is it as this pre-authorization process is happening, this is where your doctor becomes such a key player in your care because the more they know about you and the more they know about what is needed to cover the drug, the more quickly you're going to get that prior authorization approved.
SPEAKER_00And I think what's important to know here is in 2020, let's see, in 2026, Medicare Part D, the drug plan, had a$2,100 cap, meaning that you as the patient had had to spend$2,100. And after that point in time, you moved into the catastrophic phase of coverage, meaning that you had no more prescription drug cost. But no, in 2027, that cap is now going to be$2,400.
SPEAKER_00And that$2,400, once you and you know, whatever, whoever makes payments on your behalf, once you pay that amount, you will have zero cost on the prescription drug side of things. So that I know is a change that's come to part D in the new year, which we all are going to be impacted by.
SPEAKER_01Yeah, absolutely. And thankfully there is a cap. I mean, some of these medications are extraordinarily expensive. And I'm sure you could probably meet your cap just after one kind of month or administration of some of these medications. So thankfully there is a cap for people with Medicare and how much they can spend on their drugs each year. And um, you know, that's a that's a real hardship for people. And and so is there anything patients can do to help defray some of these costs to lighten their financial load?
SPEAKER_00Sure, sure. It is, I think probably most of our patients could speak to after a month of treatment, they've already let that cap and beyond, for sure. For sure. Yeah, there indeed are programs that can help. There are patients uh there are federal programs and um available through Medicare, and they're called the Medicare Savings Programs. And the one I want to talk about is much more designed for prescription drugs. I always say any program that is complicated or if any kind of federal program always always has more than one name.
SPEAKER_00It's called the Extra Help Program and andor the low-income subsidy program. All right. And what it does, it really helps reduce costs of prescription drugs. What it does is if you have an income below certain amounts and you have like savings, they call it asset tests. If you have an income below a certain amount and assets below a certain amount, you can be potentially eligible on. And I'll talk about those in a minute.
SPEAKER_00But what it does is it really, it really removes your uh Part D drug premium. It'll pay that for you. And then it'll tell it'll cap the amount you're gonna pay for a drug. It'll, and it's we're talking about like, you know,$5.80 for a generic drug or$14 for a brand name drug. So you can see it really can reduce your out-of-pocket expenses. But to give people an idea of what those thresholds are in order to be eligible for this federal program, it is that you, as an individual, you would have to make less than$24,000 a year or just slightly above that, as far as income goes.
SPEAKER_00If you were a married couple or you have you and you and your spouse, then you would have to make under$32,000 a year. So you could see those are pretty low incomes. And similarly, the amount you can have in savings, you know, in your bank accounts or in your checking accounts, it would be for an individual person, it would be just over$18,000 a year. And for a couple, it would be just over$36,000 a year.
SPEAKER_00So what I would say if you think that you're close to those income levels or asset levels, then you should talk to your state health insurance assistance program, the ship programs, and you can find that information at www.shiphelp.org, and they can help you with that kind of application. Okay. The other thing I do want to mention, if you don't think that you're going to be eligible for this type of assistance through the federal program, what some patients end up doing is because you have this.
SPEAKER_00Normally we have a pretty high drug deductible in a lot of these plans, is what they do is it it allows you to get past the deductible. Maybe it's like a$700 to dollar deductible. It allows you to pay incrementally over the 12 year 12 months of the year to play a flat to pay a flat amount until you meet that deductible or meet your out-of-pocket expenses. And that way it doesn't change what you owe. It just means you don't owe it all at one time. And that is something that you can enroll with.
SPEAKER_00If you join a drug plan, your drug plan can help you enroll into the Medicare prescription payment plan. So that's what's available basically from the federal level and what Medicare provides as far as assistance goes.
SPEAKER_01Okay. So on the non-federal side, you know, there we know there's a lot of patients who get um assistance, you know, covering their drugs through charitable foundations. A couple are total assist or health well. And how does Medicare work with these programs to assist patients?
SPEAKER_00Right. Right. Well, you know, with the with this kind of programs, I think it's important when you start looking at um how how charitable organizations participate in this, I think it's important to understand why they even exist and and and all that. And I think what maybe folks don't understand is uh really there's federal law, and it's called the anti-kickback statutes that make it illegal for drug companies to directly give drugs to patients, or directly not even give drug to patients, but give financial discounts or coupon cards or any kind of copay cards to anyone enrolled in Medicare.
SPEAKER_00Because they consider these things like coupons or discounts to be as inducements, as a way of buying your buying your participation with our drug and you taking your drug. So that is why these charitable charitable programs do exist, because the drug companies are blocked from giving you any kind of assistance. And so, therefore, these charitable uh organizations such as Total Assist or Health Well, they're separate from the drug companies and they're a legal alternative to allow patients to get assistance, okay?
SPEAKER_00And Medicare allows the charities to basically pay these out of the Medicare out-of-pocket costs for the patients. And then um, so if the if the Medicare uh or if this if this um charity is paying your out-of-pocket costs, it's paying till you pass surpass that$700 deductible. It covers that deductible for you. It will pay that$2,400 out-of-pocket max that you would have.
SPEAKER_00So therefore, you would then be eligible to get drugs for free for the rest of the year. So, what it's doing is these charitable programs are making, giving grants and saying, here, take this, take this card. And what it does is allow you to purchase one of these amyloidosis drugs up until you reach that$2,400 cap, and then Medicare will cover the remainder, the remainder of the cost of that drug for the year.
SPEAKER_00So it's kind of a stopgap way of helping patients through those financial hurdles. So hopefully that helps people understand how these programs really allow patients to forego the financial hurdles of all this out-of-pocket expense. Okay. And again, I know that the different programs operate a little bit differently. They have their own requirements in terms of what kind of income you can have and who can participate.
SPEAKER_00So I know you're going to have to complete an application to health. Well, complete an application to total assist. And I do know that both of them do have amyliodosis funds. Um, and I guess there is a question of whether those funds, how long they remain open every year. So that's like so it's not a slam dunk all the time. You're gonna have to make sure there's an amyloidosis fund that is open and able to give grants. And then what's the dollar amount of that grant? And hopefully, if you can get one of the grants, it could help you um meet those costs that you have for your amyloidosis treatments.
SPEAKER_01Yeah. Like you said, certainly a a bit of work to really qualify for these programs. But, you know, thankfully they're available to patients because they really can. Just reduce one less burden that these patients are already dealing with.
SPEAKER_00Yeah. It's it's hard. Like you think about all the things you're already, all the stress you're already under, and then this happens. But before we move further, I want to make sure I mean mention one more type of assistance program. Okay.
SPEAKER_01Yeah, absolutely.
SPEAKER_00And that is the patient assistance program, which is different from a charitable organization. And this is where the actually the drug manufacturer actually does give the drug to the patient directly. And really what you're doing is foregoing any insurance involvement. So you're basically foregoing Medicare in this saying. So you're not going to bill Medicare for the drugs that was get that were given to you by the patient assistance program. And I know Pfizer has one, something called like Ven Assist, that that's exactly what they do do.
SPEAKER_00And they'll ship, they'll ship that directly to the patient's home at no cost. And therefore, Medicare is not involved at the interesting.
SPEAKER_01So we talked a little bit about kind of the the public, the government federally funded programs, some of the options through charitable organizations. But there's another way for patients to get these medications, and that's through clinical trials. So I'd love to hear a little bit about how Medicare is involved and covers the medications that patients receive through these clinical trials.
SPEAKER_00Oh, for sure, for sure. Yeah. And I think, you know, when we say clinical trials, I think for the most part, people do indeed know what we're talking about. It's these are really research studies that are designed to explore whether, you know, a particular drug or medical strategy or treatment or device is safe for patients. And normally Medicare will cover the routine costs that are normally covered by Medicare. But it will only cover those kinds of routine lab works or doctor's visits or hospital monitor monitorings if the uh clinical trial number one has a national clinical trial number, this NCT number, meaning it's kind of been vetted uh by the federal government or by CMS.
SPEAKER_00And it wants to make sure it's following all the safety and efficacy standards. And I know you can find most of those at uh clinicaltrials.gov. That's one place to learn more about clinical trials that do have this national clinical trial number. The other piece you want to know, Medicare, like I said, will cover a lot of the routine costs, but it will not cover any of the costs of the this experimental drug or device. That's all going to be something that's going to hopefully be on whoever's sponsoring, whoever's running this clinical trial.
SPEAKER_00And what I will say is what I think if you're going to be involved in one of these, you as far as insurance coverage perspective, it may be that the trial would like to have a test done more frequently than Medicare would normally cover it. So you're going to have to know if if that's being done because the drug manufacturer wants to know how the drug is interacting with you more frequently than Medicare normally runs that type of blood test, for example, that's going to likely be either your cost or a cost of the clinical trial.
SPEAKER_00Medicare is not likely going to cover that. So what your job is really going to need to be is you're going to need to understand who's paying for what when you sign up for this clinical trial. And you're going to really want to know, you're going to have all this explained to you and know if you're going to get any kind of billing issues, who do you turn to on the clinical trial to help you resolve some of this? I mean, you're, you know, you're going to want to make sure that you understand what you're getting into and if you're going to be financially exposed in any way, shape, or form.
SPEAKER_01Well, Anne, I want to thank you so much for your time today and sharing your valuable expertise about Medicare. It really is fantastic for our audience and something that I bet the vast majority of our listeners will find helpful. And, you know, you taking your time is also another way to help remember your husband John and his battle with AL amyloidosis. And so, you know, we're so grateful. And in closing, would love to offer you the opportunity to offer a parting message to our audience if you have one.
SPEAKER_00Well, thank you, Mc Mackenzie. Thank you so very much. You know, uh it for me, as we discuss um all of this, as we discuss all this, what what comes to the fore for me really is how important it is to work with a doctor or provider that has a lot of experience with treating amyloidosis. You know, and these are things like you find at amylidosis centers of excellence. And and and if you can't get to one to be able to consult with someone at a center of excellence is so important.
SPEAKER_00I do really remember when John was early in his diagnosis stages, it took a long time for us to find someone who really knew what they were doing. And once we found someone, we found a provider that knew what they were doing, it really eased our path in so many ways. I mean, what they could do for us is number one, an experienced provider who has a lot of experience working with amylosis not only has expertise in treating the disease, we know that they're the staff that they work with, whether it's the billing staff or the nursing staff, they have coding and they know how to bill something or how to code something.
SPEAKER_00And that really paves the way for more quick coverage. All these things we've talked about in terms of prior authorization. If you have an office staff that knows what insurance companies are looking for, they do that the first time and it no longer delays coverage. So, and likely they're also familiar with these assistance programs. So you could see how the path is so much clearer if you're working with a with an office that knows a lot about amyloidosis.
SPEAKER_00And I just hope, you know, by opening up these ideas for consideration, people have, you know, more information on their arsenal that when they go to talk to a doctor, and we could potentially even reduce some of the confusion or stress that they have because, you know, the cost and coverage of covenant covering amyloidosis, it's staggering. And less people need to be as worried about this. They want to be there for their loved one and and be very present for them in their daily lives.
SPEAKER_00So let's hope it helps.
SPEAKER_01Absolutely. I know, you know, over the course of these two episodes, you've really imparted uh a lot of wonderful wisdom for our patients. And like you said, just kind of one less thing to worry about. There's a resource for them that um they could learn more. So for our listeners out there today, in part two of our Medicare discussion, our expert Ann offered some information about the different ways that doctors participate with Medicare and how these participation rules directly impact the patient's out-of-pocket costs. And we also discussed how and where Medicare covers some of the most common and again expensive amyloidosis treatments and where people can turn if and when those costs become too much to bear.
SPEAKER_01Lastly, we learned what you can expect Medicare to cover if you find yourself enrolled in a clinical trial. And again, this is part two of a two-part discussion on Medicare. So please see our recent part one episode, which I think does a really wonderful job of laying the foundation for our discussion today. And together we've learned excellent information about Medicare for the amyloidosis community, which we hope you'll find help. Thank you for listening to the All Things Amyloid Podcast.
SPEAKER_01If you find our podcast informative, please follow and share it with others. If you want to learn more about the work we're doing at Mackenzie's Mission, please visit mm713.org. We'd also like to thank AstraZeneca Pharmaceuticals, Alexion Pharmaceuticals, Al Nylon Pharmaceuticals, and Bridge Biopharma for their sponsorship to help raise awareness about amyloidosis. We hope you stay tuned for future episode drops. Thanks for listening.
Send us Fan Mail Adapted from his video, in this episode of All Things Amyloid, Dr. Mat Maurer, cardiologist at Columbia University Irving Medical Center discusses the importance of developing a broad differential in...
Send us Fan Mail Caregiving seems to be a universal role that many of us play at some time in our lives, whether we are ready for it or not. It may be for a child, parent, spouse, family member, or friend who is facing...
Send us Fan Mail It’s that time of year for Medicare Open Enrollment - a season that impacts so many of our amyloidosis patients. I’ll be speaking with Ann Kayrish, an expert in this area and someone who worked for...
Send us Fan Mail Amyloidosis patients often experience GI issues, both before and after diagnosis. The commonness of these symptoms can increase the difficulty of diagnosing amyloidosis. Adapted from her video...
Send us Fan Mail In today’s episode we’ll be talking about that invisible fight that every patient with a challenging disease goes through … the battle of emotional health. What amplifies this fight is that it is...